Last reviewed · How we verify

NCT06058806

Effects of Multimodal Physical Therapy in Patients With Lumbosacral Radiculopathy

Completed NA Last updated 28 September 2023
What this trial tests

NA trial testing Multimodal Physical Therapy in Lumbosacral Radiculopathy in 14 participants. Completed in 20 January 2020.

Timeline
1 June 2018
Primary endpoint
20 January 2020
20 January 2020

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment14
Start date1 June 2018
Primary completion20 January 2020
Estimated completion20 January 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 45, any sex, with Lumbosacral Radiculopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purposes of the study To investigate the effect of Multimodal Physical Therapy on pain, daiablility H-reflex, and Diffusion Tensor Imaging (DTI) Parameters in Patients With Lumbosacral Radiculopathy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of Multimodal Physical Therapy on Pain, Disability, H-reflex, and Diffusion Tensor Imaging Parameters in Patients With Lumbosacral Radiculopathy Due to Lumbar Disc Herniation: A Preliminary Trial.
    Badr M, Elkhawaga H, Fawaz K, Kasem M, et al · · 2024 · cited 1× · PMID 39081452 · DOI 10.7759/cureus.63501

Verify or expand the search:

Other recruiting trials for Lumbosacral Radiculopathy

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06058806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing